Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 203

Similar articles for PubMed (Select 2059368)

1.

2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals.

Witt PL, Spear GT, Lindstrom MJ, Kessler HA, Borden EC, Phair J, Landay AL.

AIDS. 1991 Mar;5(3):289-93.

PMID:
2059368
2.

The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV.

N Engl J Med. 1990 Jan 18;322(3):166-72.

3.

Immune activation markers and AIDS prognosis.

Osmond DH, Shiboski S, Bacchetti P, Winger EE, Moss AR.

AIDS. 1991 May;5(5):505-11.

PMID:
1677808
4.

Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.

Whittle H, Egboga A, Todd J, Corrah T, Wilkins A, Demba E, Morgan G, Rolfe M, Berry N, Tedder R.

AIDS. 1992 Jul;6(7):685-9.

PMID:
1354448
5.

Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.

Jacobson MA, Bacchetti P, Kolokathis A, Chaisson RE, Szabo S, Polsky B, Valainis GT, Mildvan D, Abrams D, Wilber J, et al.

BMJ. 1991 Jan 12;302(6768):73-8.

6.

[Changes in serum levels of beta 2-microglobulin, neopterin and 2',5'-oligoadenylate synthase activity during clearance of hepatitis B virus with or without acute phase in transaminases].

Carreño García V, Hernández-Guío C, Bartolomé Nebreda J, Quiroga Estévez JA.

Rev Esp Enferm Dig. 1993 Mar;83(3):169-75. Spanish.

PMID:
7683894
7.

Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy.

Siller L, Martin NL, Kostuchenko P, Beckett L, Rautonen J, Cheng SC, Wara DW.

AIDS. 1993 Mar;7(3):369-73.

PMID:
8097095
8.

[Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].

Antón F, Labarga P, Pinilla J, Soto MJ, Leoz A, del Cura J, Borque L, Milazzo A.

Enferm Infecc Microbiol Clin. 1993 Aug-Sep;11(7):373-7. Spanish.

PMID:
8104488
9.

Elevated serum calprotectin levels in HIV-infected patients: the calprotectin response during ZDV treatment is associated with clinical events.

Müller F, Frøland SS, Aukrust P, Fagerhol MK.

J Acquir Immune Defic Syndr. 1994 Sep;7(9):931-9.

PMID:
7914232
10.

Close relationships between neopterin and beta-2-microglobulin levels in intravenous drug abusers.

Lin RY, Nygren E, Valinsky J, Lorenzana FG, Ralph H.

Int Arch Allergy Appl Immunol. 1990;91(4):389-93.

PMID:
1976599
11.

Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS.

Krown SE, Niedzwiecki D, Bhalla RB, Flomenberg N, Bundow D, Chapman D.

J Acquir Immune Defic Syndr. 1991;4(9):871-80.

PMID:
1895208
12.

[Serum adenosine deaminase in human immunodeficiency virus infection. Its relationship with CD4+ lymphocytes and beta 2-microglobulin].

Iñigo MA, Ruiz López de Tejada M, Torres-Tortosa M, Sánchez-Porto A, Ugarte I, García de Lomas E, Morán Nestares A.

Med Clin (Barc). 1992 Dec 12;99(20):766-8. Spanish.

PMID:
1361013
13.

[HIV-1 antigenemia and T-cell activation in HIV-1 infected patients].

Harrer T, Wolf B, Kersten W, Schwarz W, Bergner D, Kalden JR.

Klin Wochenschr. 1990 Sep 3;68(17):864-8. German.

PMID:
2214610
14.

Early markers of HIV infection and subclinical disease progression.

Dolan MJ, Lucey DR, Hendrix CW, Melcher GP, Spencer GA, Boswell RN.

Vaccine. 1993;11(5):548-51.

PMID:
8098175
15.

Early levels of CD4, neopterin, and beta 2-microglobulin indicate future disease progression.

Shi M, Taylor JM, Fahey JL, Hoover DR, Muñoz A, Kingsley LA.

J Clin Immunol. 1997 Jan;17(1):43-52.

PMID:
9049785
16.
17.

Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.

Krämer A, Biggar RJ, Hampl H, Friedman RM, Fuchs D, Wachter H, Goedert JJ.

Am J Epidemiol. 1992 Jul 1;136(1):71-80.

PMID:
1384311
18.

Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users.

Chaisson RE, Taylor E, Margolick JB, Muñoz A, Solomon L, Cohn S, Nelson KE, Vlahov D.

J Acquir Immune Defic Syndr. 1992;5(5):456-60.

PMID:
1348535
19.

The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals.

Bass HZ, Hardy WD, Mitsuyasu RT, Taylor JM, Wang YX, Fischl MA, Spector SA, Richman DD, Fahey JL.

J Acquir Immune Defic Syndr. 1992;5(3):215-21.

PMID:
1346807
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk